Human B7-1, Mouse IgG2a Fc Tag, low endotoxin on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Human CTLA-4, His Tag at 1 ug/mL (100 uL/well) can bind Human B7-1, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 2-31 ng/mL.
Immobilized Human B7-1, Mouse IgG2a Fc Tag, low endotoxin at 5 ug/mL (100 uL/well) can bind Human PD-L1, Fc Tag with a linear range of 0.01-0.313 ug/mL.
Serial dilutions of Ipilimumab were added into Human B7-1, Mouse IgG2a Fc Tag, low endotoxin: Biotinylated Human CTLA-4, Fc,Avitag binding reactions. The half maximal inhibitory concentration (IC50) is 0.8402 ug/mL.
Immobilized Biotinylated Mouse CD28, His,Avitag at 1 ug/mL (100 uL/well) on Streptavidin precoated (0.5 ug/well) plate, can bind Human B7-1, Mouse IgG2a Fc Tag, low endotoxin with a linear range of 0.2-5 ng/mL.
Loaded Human B7-1, Mouse IgG2a Fc Tag, low endotoxin on Protein A Biosensor, can bind Human / Cynomolgus / Rhesus macaque CD28, His Tag with an affinity constant of 4.6 uM as determined in BLI assay (ForteBio Octet Red96e).
Flow Cytometry assay shows that Human B7-1, Mouse IgG2a Fc Tag, low endotoxin can bind to 293 cell overexpressing human CTLA-4. The concentration of Human B7-1 is 1 ug/mL.
FACS analysis shows that the binding of Human B7-1, Mouse IgG2a Fc Tag, low endotoxin to 293 overexpressing CTLA-4 was inhibited by increasing concentration of neutralizing Anti-human CTLA-4 antibody. The concentration of Human B7-1 is 1 ug /mL. The IC50 is 5.5 ug/mL.
Immobilized Human / Cynomolgus / Rhesus macaque CD28, Fc Tag (HPLC-verified) on CM5 Chip can bind Human B7-1, Mouse IgG2a Fc Tag, low endotoxin with an affinity constant of 2.72 uM as determined in a SPR assay (Biacore T200).